Print Programme

Wednesday, 9 October 2019

18:00 -19:00

19:00 - 20:30
  

 

 




20:30 - 22:00

WELCOME DINNER

OPENING SYMPOSIUM

Chair: Kah-Whye Peng
 
Kah-Whye Peng
, Mayo Clinic Rochester
"Welcone"
Robert Martuzam, Massachusetts General Hospital
'Introduction"
INV01 - Keynote: Tomoki Todo, The University of Tokyo
"Clinical development of oncolytic herpes virus G47?"

WELCOME RECEPTION

 

Thursday, 10 October 2019

07:30 - 08:30 BREAKFAST
08:30  - 10:00

SCIENTIFIC SESSION 1: Virus and Host Interactions 
Chairs: Grant McFadden and Martine Lamfers


INV02 - Liang Deng, Memorial Sloan Kettering Cancer Center
"Rational engineering of vaccinia viruses for cancer immunotherapy"
INV03 - Glen Barber, University of Miami
"How a virus stimulates innate immunity and exploits defects in tumor"

OR01 - TBC
OR02 - TBC

10:00   - 10:30 COFFEE BREAK
10:30  – 12:30

SCIENTIFIC SESSION 2: Virus and Host Interactions 
INV04 -Jing Qing. Amgen
“Mechanisms of OncoVEXmGM-CSF-induced durable and systemic anti-tumor immunity in preclinical models”?
INV05 - Kevin Harrington, Institute of Cancer Research, London
"Pharmacological modulation of oncolytic virotherapy; in search of synthecally lethal combinations"

OR03 - TBC
OR04 - TBC
OR05 - TBC
OR06 - TBC

12:30  – 13:30 LUNCH BREAK
13:30  – 14:45

SCIENTIFIC SESSION 3: Virus and Host Interactions 
Chairs: John Bell and Nori Kasahara


INV06 - Valery Grdzelishvili, UNC Charlotte
"Understanding and breaking multiple mechanism of resistance of pancreatic cancer cells to oncolyitc viruses"

OR07 - TBC
OR08 - TBC
OR09 - TBC

14:45   - 15:00 COFFEE BREAK
15:00   - 16:15

INV07 -Dimitry Zamarin, Memorial Sloan Kettering Cancer Center
"Modulation of Newcastle Disease Virus-activated anti-tumor immunity"

OR10 - TBC
OR11- TBC
OR12 - TBC

16:30   - 18:00

SCIENTIFIC SESSION 4: The Great Debate
Chairs: Kerry Fisher and Stephen Russell


Richard Vile (Mayo Clinic) vs. Len Seymour (Oxford University)
"OV as antigen agnostic cancer vaccines"

18:30   - 21:00

CONFERENCE DINNER
Dan Abraham Healthy Living Center 
(transport from the venue @18.30)

 

Friday 11 October 2019

08:30  -  10:00

SCIENTIFIC SESSION 5: Engineered Viruses and cancer vaccines
Chairs: Sam Rabkin and Eva Galanis


INV11 Lelia Delamarre, Genenetech  
"Neoantigen personalized vaccines"

INV12 - Autumn Schulze, Mayo Clinic, Rochester
"Synthetic Infectious RNA for Oncolytic Virotherapy"
OR13 - TBC
OR14 - TBC

10:00   - 10.30 COFFEE BREAK
10:30  -  12:30

SCIENTIFIC SESSION 6: Keynote lecture and top abstracts
Chair and introduction: Stephen J Russell

Sponsored by ASGCT

INV13 - Rosalind Carter, CDC, Atlanta
TOP ABSTRACTS
OR15 - TBC
OR16 - TBC
OR17 - TBC

12:30   - 13:30 LUNCH
13:30   - 14:35

SCIENTIFIC SESSION 7: Engineered Viruses, late phase clinical trials
Chair: John Beadle


INV14 - Paola Grandi, Cold Genesys
INV15 - Hideki Kasuya, Nagoya University
"Clinical development of Canerpaturev (formerly HF10) as the novel cancer therapy"

OR18 - TBC
OR19 - TBC
OR20 - TBC

14:35   - 15:00 COFFEE BREAK
15.00  - 16:15

SCIENTIFIC SESSION 8: New technology platforms from OV companies
Chair: Frank Tufaro and David Stojdl

INV16 - Chae-Ok Yun
, GeneMedicine, Seoul
"Exploring hydrogel system to enhance the therapeutic efficacy of oncolytic adenovirus"
INV17 - OncoMyx
INV18 - TBC
INV19- TBC

16.15   - 18:15

POSTER SESSION
Wine and cheese

18:15 - 21:00 FACULTY & INVITED SPEAKER DINNER (by invitation only)
Foundation House
(transport from the venue @18.15) 
 

Saturday 12 October 2019

08:30   - 10:00

SCIENTIFIC SESSION 10:  Personalized OV therapy
Chairs: Brian Lichty and
Samuel Rabkin

INV20 - Martine Lamfers , Erasmus MC Rotterdam
"
Development of patient-derived glioblastoma model systems to predict response to OV therapy"
INV21 - Eva Galanis, Mayo Clinic, Rochester
"Optimizing delivery and personalizing virotherapy treatment;  the measles experience"

OR21 - TBC
OR22- TBC

10:00   - 10:30 COFFEE BREAK
10.30   - 12:15

SCIENTIFIC SESSION 11: GBM focus session and panel discussion
INV22 - Nino Chiocca, Brigham and Women’s Hospital, Harvard Medical School
"Clinical Trials of Immunovirotherapy in Recurrent Glioblastoma (GBM)"
INV23 - Annick Desjardins, Duke University
INV24 - Frank Tufaro, DNAtrix, Inc
INV25 - Doug Jolly, Tocagen, Inc

Panel discussion: 
Chairpersons:
Nino Chiocca and Robert Martuza
Panel members: Annick Desjardins, Frank Tufaro, Doug Jolly, Tomoki Todo

12:15   - 13:45 LUNCH
14.00   - 14:45

SCIENTIFIC SESSION 12: Tumor microenvironment
Chairs: Autumn Schulze and Sam Rabkin


INV26 - 
INV27 - Balveen Kaur, University of Texas Health Science Centre, Houston

OR23 - TBC
OR24 - TBC
OR25 - TBC

14.45   - 15:15 COFFEE BREAK
15.15   - 17:30

SCIENTIFIC SESSION 13: Activating the immune system
Chairs: Kah-Whye Peng and Tomoki Todo

INV28 - John Bell, Ottawa Health Research Institute
"Planting bombs inside tumours"
INV29 - Gabriella Campadelli-Fiume, University of Bologna
Second generation retargeted oHSV's primed for checkpoint blocade"

OR26- TBC
OR27 - TBC
OR28 - TBC
OR29 - TBC
OR30 - TBC

GOLDEN VIRUS AWARD
Conrad Prizes
(courtesy of DNAtrix)
IOVC Travel Awards

19.00   - 23:00

FAREWELL DINNER & DANCE
@Landow Atrium in Gonda Building
Best Poster & Best Oral Prizes, Golden Virus Award
Music by: Brian Kinney Band from Minneapolis